Product
Henagliflozin and Metformin
1 clinical trial
2 indications
Indication
Type 2 Diabetes MellitusIndication
Nonalcoholic Fatty Liver DiseaseClinical trial
Effect of Henagliflozein on Hepatic Fat Content in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Multicenter, Randomized, Controlled Clinical TrialStatus: Recruiting, Estimated PCD: 2026-11-01